|Articles|January 1, 2002
Early signs vital in bioterrorism
New York-Biological and chemical warfare have moved to the forefrontof America's consciousness, but many ophthalmologists do not know enoughabout the ophthalmic manifestations of these weapons to make a meaningfulcontribution to the care of victims.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
3
Alcon raises offer in amended deal to acquire STAAR Surgical
4
Neurotrophic keratitis outcomes improve with early, stage-based care
5









































.png)


